Stifel Financial
MDCO

Stifel Financial’s Medicines Co MDCO Stock Holding History

Stifel Financial’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-21,234
Closed -$1.8M – 3208
2019
Q4 		$1.8M Sell
21,234
-38,080
-64% -$2.54M ﹤0.01% 1402
2019
Q3 		$2.97M Buy
59,314
+2,195
+4% +$87.6K 0.01% 1063
2019
Q2 		$2.08M Buy
57,119
+27,404
+92% +$895K 0.01% 1299
2019
Q1 		$833K Buy
29,715
+9,329
+46% +$220K ﹤0.01% 1764
2018
Q4 		$388K Buy
20,386
+10,546
+107% +$245K ﹤0.01% 2092
2018
Q3 		$291K Buy
+9,840
New +$371K ﹤0.01% 2383
2017
Q1 		– Sell
-9,667
Closed -$329K – 2636
2016
Q4 		$329K Buy
9,667
+4,147
+75% +$147K ﹤0.01% 1992
2016
Q3 		$209K Buy
+5,520
New +$208K ﹤0.01% 2158
2014
Q2 		– Sell
-10,000
Closed -$284K – 2287
2014
Q1 		$284K Buy
+10,000
New +$331K ﹤0.01% 1758

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Stifel Financial's MDCO Position: Q1 2020 in Review

Stifel Financial sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 21,234 shares — an estimated $1.8M sold.

Stifel Financial first reported a position in MDCO in Q1 2014 and held it in 9 quarters. The position peaked at $2.97M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Stifel Financial reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Stifel Financial sold 21,234 Medicines Co shares in Q1 2020, an estimated $1.8M.
  • Stifel Financial first reported a position in Medicines Co in Q1 2014 and held it in 9 quarters.
  • Stifel Financial's Medicines Co position peaked at $2.97M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Stifel Financial's 13F filing for Q1 2020, filed 14 May 2020.